Stage

Acquired - II

Investors Count

5

Portfolio Exits

1

Funding, Valuation & Revenue

4 Fundings

Accumen's latest funding round was a Acquired for on October 22, 2024.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/22/2024

Acquired

$XXM

0

FY undefined

2

1/17/2019

Acq - Fin

$XXM

0

FY undefined

10

1/1/2011

Series A

$XXM

0

FY undefined

10

Other Investors

$XXM

0

FY undefined

10

Date

10/22/2024

1/17/2019

1/1/2011

Round

Acquired

Acq - Fin

Series A

Other Investors

Amount

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

10

10

10

Start free trial
New call-to-action

Accumen Investors

5 Investors

Accumen has 5 investors. hc1 invested in Accumen's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/22/2024

10/22/2024

1
Acquired

Corporation

Indiana

00/00/0000

00/00/0000

Arsenal Capital Partners

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

Accretive

Subscribe to see more

Private Equity

New York

Activate Venture Partners

Subscribe to see more

Venture Capital

New York

Rittenhouse Ventures

Subscribe to see more

Venture Capital

Pennsylvania

First funding

10/22/2024

00/00/0000

00/00/0000

Last Funding

10/22/2024

00/00/0000

00/00/0000

Investor

Arsenal Capital Partners

Accretive

Activate Venture Partners

Rittenhouse Ventures

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Private Equity

Private Equity

Venture Capital

Venture Capital

Location

Indiana

New York

New York

New York

Pennsylvania

Accumen Acquisitions

4 Acquisitions

Accumen acquired 4 companies. Their latest acquisition was 3D Robotics on October 30, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/30/2019

Debt

$XXM

$178.95M

Acquired

2

10/23/2019

Series B

Subscribe to see more

$XXM

$XXM

Subscribe to see more

10

6/17/2019

Convertible Note

Subscribe to see more

$XXM

$XXM

Subscribe to see more

10

4/5/2016

Subscribe to see more

$XXM

Subscribe to see more

10

Date

10/30/2019

10/23/2019

6/17/2019

4/5/2016

Investment Stage

Debt

Series B

Convertible Note

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$XXM

$XXM

$XXM

$XXM

Total Funding

$178.95M

$XXM

$XXM

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

Accumen Portfolio Exits

1 Portfolio Exit

Accumen has 1 portfolio exit. Their latest portfolio exit was 3D Robotics on June 11, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/11/2021

Acquired - II

$XXM

1

Date

6/11/2021

Exit

Acquired - II

Companies

Valuation

$XXM

Acquirer

Sources

1

New call-to-action

Compare Accumen to Competitors

Transcarent Logo
Transcarent

Transcarent provides health and care services. The company offers a suite of services, including healthcare navigation, virtual and in-person care, pharmacy care, and health programs, designed to guide members through health journeys. Transcarent primarily serves members, employers, consultants, and labor unions. It was founded in 2020 and is based in Denver, Colorado.

Maven Logo
Maven

Maven is a virtual clinic specializing in women's and family health across various life stages. The company offers digital programs that provide clinical, emotional, and financial support for fertility and family building, maternity and newborn care, parenting and pediatrics, as well as menopause and midlife health. Maven serves employers, health plans, and consultants. It was founded in 2014 and is based in New York, New York.

HealthSherpa Logo
HealthSherpa

HealthSherpa is a platform in the health insurance sector, focusing on ACA quoting and enrollment services. The company provides a technology platform that enables insurance agents and agencies to enroll clients in ACA and Medicare health plans, offering tools for quoting, plan comparison, and client management. HealthSherpa's services aim to assist in the enrollment process and improve the workflow of agents and agencies in serving their clients. It was founded in 2013 and is based in San Francisco, California.

Lyra Health Logo
Lyra Health

Lyra Health offers workforce mental health benefits within the healthcare sector. It provides provider matching, support, and a digital platform that delivers mental health care. Lyra Health primarily serves employers looking to offer mental health benefits to the workforce. It was founded in 2015 and is based in Burlingame, California.

HealthJoy Logo
HealthJoy

HealthJoy is a care navigation platform in the healthcare sector. The company offers services including virtual musculoskeletal care, urgent care, behavioral health, primary care, chronic care management, employee assistance programs, and access to surgery centers. These services aim to guide employees to care options and support overall wellbeing. It was founded in 2014 and is based in Chicago, Illinois.

S
Spirig HealthCare

Spirig HealthCare is a company involved in the development and distribution of pharmaceutical products. Its offerings include generics, specialty-care products, and over-the-counter medications. The company serves medical professionals and patients. It is based in Egerkingen, Switzerland.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.